Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
View through CrossRef
ABSTRACT Objective To assess safety of the switch between natalizumab and fingolimod without a washout period. Methods Prospective data on 25 JCV positive patients who underwent this medication switch were collected and analyzed. Results After a median period of nine months from the medication switch, there were no safety issues to report. The patients had good disease control and no adverse events were reported. Conclusion Washout may not be necessary in daily practice when switching from natalizumab to fingolimod. Expertise on multiple sclerosis management, however, is essential for drug switching.
FapUNIFESP (SciELO)
Title: Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
Description:
ABSTRACT Objective To assess safety of the switch between natalizumab and fingolimod without a washout period.
Methods Prospective data on 25 JCV positive patients who underwent this medication switch were collected and analyzed.
Results After a median period of nine months from the medication switch, there were no safety issues to report.
The patients had good disease control and no adverse events were reported.
Conclusion Washout may not be necessary in daily practice when switching from natalizumab to fingolimod.
Expertise on multiple sclerosis management, however, is essential for drug switching.
Related Results
Treatment with natalizumab and ocrelizumab in multiple sclerosis
Treatment with natalizumab and ocrelizumab in multiple sclerosis
In this thesis, our research regarding personalized treatment with natalizumab and ocrelizumab in multiple sclerosis (MS) by extending treatment intervals and the road towards impl...
Fingolimod Regulates BDNF-AS and HOTAIR Expression in Multiple Sclerosis Patients
Fingolimod Regulates BDNF-AS and HOTAIR Expression in Multiple Sclerosis Patients
AbstractBrain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, is expressed by neurons and glial cells in the central nervous system (CNS). In the CNS, BDNF...
Narrative review based on fingolimod therapy in pediatric MS
Narrative review based on fingolimod therapy in pediatric MS
The course of pediatric-onset multiple sclerosis and adult multiple sclerosis shows some clinical differences. The rate of having a second attack after the first clinical event is ...
Sequence of cardiovascular autonomic alterations after fingolimod initiation
Sequence of cardiovascular autonomic alterations after fingolimod initiation
BackgroundHomeostasis between heart rate and blood pressure is based on several interacting regulatory reflexes, which become influenced by fingolimod initiation. The aim of this s...
THUR 171 Natalizumab effectiveness and safety in top uk patients
THUR 171 Natalizumab effectiveness and safety in top uk patients
IntroductionThe TYSABRI® Observational Program (TOP) is an ongoing, global open-label study enrolling natalizumab-treated relapsing-remitting multiple sclerosis patients in real-wo...
Role of fingolimod in acute respiratory distress syndrome.
Role of fingolimod in acute respiratory distress syndrome.
Objective: Sphingosine 1 Phosphate (S1P) is a key regulator of inflammation, angiogenesis, vessel permeability, and immune processes, acting through S1P receptors. Fingolimod (FTY7...
Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis
Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis
Natalizumab is indicated as monotherapy for the treatment of relapsing-remitting multiple sclerosis; it prevents outbreaks and delays the progression of physical disability. Here, ...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...